期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

弥漫性大B细胞淋巴瘤t（14；18）易位和c—myc基因重排研究进展 被引量：2

Progress of t （14;18） translocation and c-myc gene rearrangement in diffuse large B-cell lymphoma
原文传递
导出
摘要 弥漫性大B细胞淋巴瘤（DLBCL）是一组B淋巴细胞来源最常见的、且具有异质性的非霍奇金淋巴瘤（NHL）。就DLBCL中t（14；18）易位和c—myc基因重排及其诊断分型、治疗和预后评价方面的最新研究进展进行综述。 Diffuse large B-cell lymphoma （DLBCL） is a heterogeneous group of tumors composed of large B cells. It is the most common type of non-Hodgkin lymphoma. As its variety of clinical, morphological and genetic characters, the classification and prognosis are still debated. This article aims to elucidate t（14;18） translocation and c-myc gene rearrangement is of great significance to the clinical diagnosis, classification, treatment and prognosis of DLBCL.
作者 张宏伟(综述) 程牛亮(审校)
机构地区 山西医科大学生物化学与分子生物学教研室
出处 《白血病．淋巴瘤》 CAS 2009年第10期630-633,共4页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 非霍奇金 淋巴瘤 弥漫型 基因重排 研究 Lymphoma, non-Hodgkin Lymphoma, diffuse Rearrangement, gene Research
分类号 R733 [医药卫生—肿瘤] R733.71 [医药卫生—肿瘤]
  • 相关文献

参考文献21

  • 1Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. //Jaffe ES, Harris NL, Stein H, et al. World health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
  • 2Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn, 2006, 8: 141-151.
  • 3Yonetani N, Ueda C, Akasaka T, et al. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5'region of bcl-2 in B-cell tumors. Jpn J Cancer Res, 2001, 92: 933-940.
  • 4Batstone PJ, Goodlad JR. Efficacy of screening the intermediate cluster region of the bcl-2 gene in follicular lymphomas by PCR. J Clin Pathol. 2005.58: 81-82.
  • 5Fenton JA, Vaandrager JW, Aart WM, et al. Follicular Lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood, 2002, 99: 716-718.
  • 6Huang JZ, Sanger WG, Greiner TC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood, 2002, 99: 2285-2290.
  • 7Iqbal J, Sanger WG, Horsman DE, et al. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-ceB lymphoma. Am J Pathol, 2004, 165: 159-166.
  • 8Nyvold CG, Bendix K, Brandsborg M. Multiplex PCR for the detection of Bcl-1/IGH and Bcl-2/IGH gene rearrangements clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected ofnon-Hodgkin lymphoma [J].Acta Oncol, 2007, 46: 21-30.
  • 9Fernandez RE, Cabrerizo M, Orteqa M, et al. High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide vincristine prednisone plus interferon alpha 2b. Clinical Cancer Research, 2003, 9: 2497-2503.
  • 10周爱萍,石远凯,冯奉仪,陆士新,何小慧,韩晓红.非霍奇金淋巴瘤自体外周血干细胞中肿瘤污染的临床研究[J].中华肿瘤杂志,2002,24(5):467-470. 被引量：10

二级参考文献21

  • 1金亦,苏祖兰,李迎春,唐录英,郭少忠,冯智英.非霍奇金淋巴瘤IgH及TCRγ基因重排的意义[J].中华血液学杂志,2004,25(10):623-624. 被引量：6
  • 2Philippe C,Gillles S,Nicole,et al. Rituximab ( anti-CD20 mono-elonal antibody ) as single first-line therapy for patients with follicular lymphoma with a low tumor burden : clinical and moleeular evaluation [ J ]. Blood, 2001, 91 ( 1 ) : 101 - 106.
  • 3Barrans SL,Evans PA,O'Connor SJ,et al. The Bc12-IgH is associated with germinal center2derived diffuse large B-cell lymphoma and is a slrong prediclor of oulcome[ J]. Clin Cancer Res,2003, 9(6) :2133 -2139.
  • 4Nyvold CG, Bendix K, Brandsborg M. Multiplex PCR for the detection of BCL-1/IGH and Bcl-2/IGH gene rearrangements-clinical validation in a prospective study of blood and bone marrow in 258 patients with or suspected of non-Hodgkin's lymphoma[ J]. Acta Oncol, 2007, 46 ( 1 ) :21 - 30.
  • 5Shiozawa E, Yamochi T, Shiozawa T, et al. Monoclonal analysis of immunoglobulin heavy chain and T-cell receptor gamma chain gene rearrangements in paraffin-embedded tissues from nonHodgkin lymphoma patients [J]. Rinsho Byori, 2007, 55 (8) : 712 -720.
  • 6Silke L, Ulrike V, Katja T, et al. Application of BIOMED-2 Primers in B-cell non-Hodgkin's lytnphomas [ J ]. Molecular Diagnostics, 2005, 7 (5) :582 - 5 10.
  • 7Fernandez-Ruiz E, Cabrerizo M,Orteqa M, et al. High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyelophosphamide vineristine prednisone plus interferon alpha 2b [J]. Clinical Cancer Research, 2003,9 (7) :2497 - 2503.
  • 8Christiane P,Carsten S,Stefan G, et al. Quantitative assessment of molecular remission after high-dose therapy with autologous stern cell transplantation predicts long-term remission in mantle cell lymphoma [ J]. Blood, 2006,107 (6) :2271 - 2277.
  • 9Shipp MA, Abeloff MD, Antman KH, et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin′s lymphomas: report of the jury. J Clin Oncol, 1999, 17:423-429.
  • 10Zwicky CS, Maddocks AB, Anderson N, et al. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin′s lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood, 1996, 88:3314-3322.

共引文献10

同被引文献34

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics[J].CA Cancer J Clin,2007,57:43-66.
  • 2Gloeckler Ries LA,Reichman ME,Lewis DR,et al.Cancer survival and incidence from the Surveillance,Epidemiology,and End Results (SEER) program[J].Oncologist,2003,8:541-552.
  • 3Stewart BW,Kleihues P.World Cancer Report[M].Lyon; IARC Press,2003.
  • 4Evan GI,Littlewood TD.The role of c-myc in cell growth[J].Curr Opin Genet Dev,1993,3:44-49.
  • 5Bassiouni A,NosseirM,ZoheiryM,et al.Immunohistochemical expression of CD95 (Fas),C-myc and epidermal growth factor receptor in hepatitis C virus infection,cirrhotic liver disease and hepatocellular carcinoma[J].APMIS,2006,114:420-427.
  • 6Ako Kikuchia,Naoya Nakamurab,Tetsuo Kuze.Characterization of de novo diffuse large B-cell lymphoma with a translocation of C-myc and immunoglobulin genes[J].Leuk Res,2008,32:1176-1182.
  • 7Kelly K,Cochran BH,Stiles CD,et al.Cell specific regulation of the C-myc gene by lymphocyte mitogene and platelet derived growth factor[J].Cell,1983,35:603-610.
  • 8Fravera RD,Wong Staal F,Gallo RC.Oncogene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemia cells of the sanle patient[J].Nature,1982,299:61.
  • 9Li Z,Calcar S,Qu C,et al.A global transcriptional regulatory role for C-Myc in Burkitt lymphoma cells[J].Proc Natl Acad Sci USA,2003,100(14):8164 -8169.
  • 10Puccik B,Kasten M,Gordano A.Cell cycle and apoptosis[J].Neoplsia,2000,2 (4):291-299.

引证文献2

二级引证文献5

白血病．淋巴瘤
2009年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部